ARS Pharmaceuticals (SPRY) Treasury Shares (2020 - 2023)
ARS Pharmaceuticals (SPRY) posted Treasury Shares of $30.8 million for Q2 2023, up 229.39% sequentially from $9.3 million in Q3 2022, and up 299.82% YoY from $7.7 million in Q2 2022.
ARS Pharmaceuticals (SPRY) Treasury Shares (2020 - 2023) Analysis & Trends
ARS Pharmaceuticals has reported Treasury Shares for 4 years, with the latest figure at $30.8 million in Q2 2023.
- Quarterly Treasury Shares rose 299.82% year-over-year to $30.8 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $30.8 million (up 299.82% YoY) and the FY2021 annual result came in at $606060.0, down 87.28% from the prior year.
- Treasury Shares grew to $30.8 million in Q2 2023 per SPRY's latest filing, from $9.3 million in the prior quarter.
- Over five years, Treasury Shares peaked at $77.1 million in Q3 2020 and troughed at $606060.0 in Q4 2021.
- A 4-year average of $21.8 million and a median of $9.3 million in 2022 frame the typical range for Treasury Shares.
- The sharpest annual moves came in 2021 and 2023: Treasury Shares sank 87.28% in 2021, then soared 299.82% in 2023.
- Over 4 years, Treasury Shares stood at $4.8 million in 2020, then tumbled by 87.28% to $606060.0 in 2021, then surged by 1440.62% to $9.3 million in 2022, then soared by 229.39% to $30.8 million in 2023.
- According to Business Quant data, Treasury Shares over the past three periods registered $30.8 million, $9.3 million, and $7.7 million for Q2 2023, Q3 2022, and Q2 2022 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | ARS Pharmaceuticals | 561.88 Mn | 418.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 30.76 Mn |
| Jun 30, 2023 | 30.76 Mn |
| Sep 30, 2022 | 9.34 Mn |
| Sep 30, 2022 | 9.34 Mn |
| Jun 30, 2022 | 7.69 Mn |
| Jun 30, 2022 | 7.69 Mn |
| Mar 31, 2022 | 4.76 Mn |
| Mar 31, 2022 | 4.76 Mn |
| Dec 31, 2021 | 606,060.00 |
| Dec 31, 2021 | 606,060.00 |
| Dec 31, 2020 | 4.76 Mn |
| Dec 31, 2020 | 4.76 Mn |
| Sep 30, 2020 | 77.07 Mn |
| Sep 30, 2020 | 77.07 Mn |
| Jun 30, 2020 | 30.42 Mn |
| Jun 30, 2020 | 30.42 Mn |
| Mar 31, 2020 | 30.42 Mn |
| Mar 31, 2020 | 30.42 Mn |